Budapest, Hungary

Janos Ori


Average Co-Inventor Count = 10.1

ph-index = 1


Company Filing History:


Years Active: 1993-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Janos Ori: Innovator in Pharmaceutical Chemistry

Introduction

Janos Ori is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on developing novel compounds that have therapeutic applications.

Latest Patents

Among his latest patents is the invention of acaricidally active tetrazine derivatives. This invention relates to novel 1,2-dihydro-1,2,4,5-tetrazine derivatives that include various halogens such as fluorine, chlorine, or bromine. Another significant patent is for a process for preparing isoquinoline compounds. This invention involves novel compounds that antagonize the effects of constrictive mediators like histamine, acetylcholine, or serotonin. These compounds demonstrate antiallergic action and possess anti-inflammatory effects, making them valuable in treating conditions such as bronchial asthma.

Career Highlights

Janos Ori is associated with Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a prominent pharmaceutical company. His work at this company has allowed him to focus on innovative solutions in drug development.

Collaborations

Throughout his career, Janos has collaborated with notable colleagues, including Kalman Takacs and Istvan Hermecz. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Janos Ori's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor in the field. His work continues to impact therapeutic applications, particularly in treating allergic and inflammatory conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…